Latest Insider Transactions at Neuro Pace Inc (NPCE)
This section provides a real-time view of insider transactions for Neuro Pace Inc (NPCE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NeuroPace Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NeuroPace Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 18
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,878
-0.09%
|
$29,268
$6.29 P/Share
|
|
Oct 17
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,294
-0.06%
|
$19,764
$6.28 P/Share
|
|
Oct 16
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,900
-0.13%
|
$41,400
$6.57 P/Share
|
|
Oct 15
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,017
-0.07%
|
$24,102
$6.5 P/Share
|
|
Oct 14
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,031
-0.07%
|
$24,186
$6.54 P/Share
|
|
Oct 11
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,572
-0.05%
|
$15,432
$6.35 P/Share
|
|
Oct 10
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,504
-0.05%
|
$15,024
$6.12 P/Share
|
|
Oct 09
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,123
-0.06%
|
$18,738
$6.1 P/Share
|
|
Oct 08
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,000
-0.11%
|
$36,000
$6.43 P/Share
|
|
Oct 07
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,910
-0.09%
|
$29,460
$6.66 P/Share
|
|
Oct 04
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,757
-0.1%
|
$34,542
$6.92 P/Share
|
|
Oct 03
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,318
-0.06%
|
$19,908
$6.97 P/Share
|
|
Oct 02
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,843
-0.07%
|
$23,058
$6.87 P/Share
|
|
Oct 01
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,882
-0.09%
|
$29,292
$6.77 P/Share
|
|
Sep 30
2024
|
Frank M Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
3,407
+0.58%
|
$20,442
$6.97 P/Share
|
|
Sep 30
2024
|
Joseph Lacob |
BUY
Grant, award, or other acquisition
|
Direct |
1,614
+15.08%
|
$9,684
$6.97 P/Share
|
|
Sep 30
2024
|
Rakhi Kumar |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+15.64%
|
$12,912
$6.97 P/Share
|
|
Sep 30
2024
|
Uri Geiger |
BUY
Grant, award, or other acquisition
|
Direct |
1,703
+16.09%
|
$10,218
$6.97 P/Share
|
|
Sep 30
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,749
-0.09%
|
$28,494
$6.73 P/Share
|
|
Sep 27
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,059
-0.09%
|
$30,354
$6.63 P/Share
|
|
Sep 26
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,821
-0.1%
|
$34,926
$6.62 P/Share
|
|
Sep 25
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,858
-0.1%
|
$35,148
$6.6 P/Share
|
|
Sep 23
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
282
-0.01%
|
$1,974
$7.54 P/Share
|
|
Sep 20
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
765
-0.01%
|
$5,355
$7.5 P/Share
|
|
Sep 13
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,993
-0.04%
|
$13,951
$7.59 P/Share
|
|
Sep 06
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11
-0.0%
|
$77
$7.5 P/Share
|
|
Sep 04
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14
-0.0%
|
$98
$7.5 P/Share
|
|
Sep 03
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,334
-2.5%
|
$9,338
$7.39 P/Share
|
|
Sep 03
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,334
-1.07%
|
$9,338
$7.39 P/Share
|
|
Sep 03
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,093
-0.04%
|
$14,651
$7.6 P/Share
|
|
Aug 30
2024
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,314
-0.08%
|
$30,198
$7.76 P/Share
|
|
Aug 20
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,045
-5.4%
|
$21,315
$7.24 P/Share
|
|
Aug 20
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,045
-2.39%
|
$21,315
$7.24 P/Share
|
|
Jul 22
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
237
-0.42%
|
$1,659
$7.65 P/Share
|
|
Jul 22
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
237
-0.19%
|
$1,659
$7.65 P/Share
|
|
Jun 28
2024
|
Frank M Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
3,141
+0.54%
|
$21,987
$7.56 P/Share
|
|
Jun 28
2024
|
Joseph Lacob |
BUY
Grant, award, or other acquisition
|
Direct |
1,488
+16.6%
|
$10,416
$7.56 P/Share
|
|
Jun 28
2024
|
Rakhi Kumar |
BUY
Grant, award, or other acquisition
|
Direct |
1,984
+17.34%
|
$13,888
$7.56 P/Share
|
|
Jun 28
2024
|
Uri Geiger |
BUY
Grant, award, or other acquisition
|
Direct |
1,570
+17.95%
|
$10,990
$7.56 P/Share
|
|
Jun 03
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,335
-2.31%
|
$8,010
$6.46 P/Share
|
|
Jun 03
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,334
-1.03%
|
$8,004
$6.46 P/Share
|
|
May 20
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,045
-4.99%
|
$21,315
$7.98 P/Share
|
|
May 20
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,045
-2.31%
|
$21,315
$7.98 P/Share
|
|
May 03
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,674
-0.14%
|
$65,436
$14.03 P/Share
|
|
May 02
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,842
-0.26%
|
$123,788
$14.01 P/Share
|
|
May 01
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,690
-0.46%
|
$219,660
$14.02 P/Share
|
|
Apr 24
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,781
-0.05%
|
$24,934
$14.06 P/Share
|
|
Apr 23
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,791
-0.63%
|
$305,074
$14.29 P/Share
|
|
Apr 22
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
237
-0.39%
|
$3,318
$14.0 P/Share
|
|
Apr 22
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
237
-0.18%
|
$3,318
$14.0 P/Share
|